INTERLEUKIN (IL)-17 AS A BIOMARKER IN ASSESSMENT OF BRONCHIAL ASTHMA SEVERITY
M. Kenawy, E., Abd El-Hafeez, H., Abd El-Ghaffar Mohamed, N., M.A. Naeem, M. (2017). INTERLEUKIN (IL)-17 AS A BIOMARKER IN ASSESSMENT OF BRONCHIAL ASTHMA SEVERITY. EKB Journal Management System, 46(2), 443-454. doi: 10.12816/0038267
Eglal M. Kenawy; Hafez Abd El-Hafeez; Nagwa Abd El-Ghaffar Mohamed; Mahmoud M.A. Naeem. "INTERLEUKIN (IL)-17 AS A BIOMARKER IN ASSESSMENT OF BRONCHIAL ASTHMA SEVERITY". EKB Journal Management System, 46, 2, 2017, 443-454. doi: 10.12816/0038267
M. Kenawy, E., Abd El-Hafeez, H., Abd El-Ghaffar Mohamed, N., M.A. Naeem, M. (2017). 'INTERLEUKIN (IL)-17 AS A BIOMARKER IN ASSESSMENT OF BRONCHIAL ASTHMA SEVERITY', EKB Journal Management System, 46(2), pp. 443-454. doi: 10.12816/0038267
M. Kenawy, E., Abd El-Hafeez, H., Abd El-Ghaffar Mohamed, N., M.A. Naeem, M. INTERLEUKIN (IL)-17 AS A BIOMARKER IN ASSESSMENT OF BRONCHIAL ASTHMA SEVERITY. EKB Journal Management System, 2017; 46(2): 443-454. doi: 10.12816/0038267